How to Get Fosamax (Alendronate) in the District of Columbia

What Is Alendronate and Why Is It Prescribed in DC?

Alendronate is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption, slowing the bone loss that drives osteoporosis-related fractures. The Fracture Intervention Trial (FIT, N=2,027), published in JAMA in 1998, showed that alendronate 10 mg daily reduced the relative risk of hip fracture by 47% and clinical vertebral fracture by 45% over three years in postmenopausal women with low bone mass [1]. Those numbers represent the clinical standard against which every subsequent bisphosphonate has been measured.

In Washington DC, roughly 1 in 5 women over age 50 has osteoporosis based on national prevalence estimates from the CDC [2]. Alendronate 70 mg once weekly is the most commonly prescribed oral formulation because weekly dosing produces equivalent bone-mineral-density gains as the original daily 10 mg regimen, with a substantially lower rate of gastrointestinal side effects [3]. The drug is listed on the FDA's Orange Book as a rated generic, meaning DC-area pharmacies carry multiple low-cost substitutes for the branded Fosamax [4].

The FDA approved alendronate for postmenopausal osteoporosis, male osteoporosis, glucocorticoid-induced osteoporosis, and Paget's disease of bone [4]. DC prescribers commonly initiate therapy in patients with a T-score at or below -2.5, or at or below -1.0 with additional FRAX fracture-risk factors, consistent with the National Osteoporosis Foundation (now Bone Health and Osteoporosis Foundation) 2022 clinical practice guideline [5].

Who Can Prescribe Fosamax in the District of Columbia?

Any licensed DC prescriber with authority to write Schedule-unscheduled prescription drugs may prescribe alendronate. That includes physicians (MD and DO), nurse practitioners (NP), and physician assistants (PA). DC's Nurse Practitioner Practice Act grants full independent prescriptive authority to advanced practice registered nurses without a physician collaboration agreement, which means NPs operating telehealth-only practices can issue an alendronate prescription without a supervising physician on file [6].

Physician assistants in DC practice under a supervision agreement, but that agreement does not need to be present at the point of care, so a PA conducting a telehealth visit may prescribe alendronate and have the supervising physician review the chart asynchronously [6]. This flexibility matters because many DC telehealth platforms staff a mix of MDs, NPs, and PAs to reduce wait times.

The American Association of Clinical Endocrinology (AACE) 2020 postmenopausal osteoporosis clinical practice guidelines state: "Pharmacological therapy is recommended for patients with osteoporosis to reduce fracture risk" and lists alendronate among first-line agents [7]. That guideline is the most commonly cited authority DC prescribers use when documenting the medical necessity of therapy for insurers.

How to Get a Fosamax Prescription in the District of Columbia

Getting an alendronate prescription in DC follows a predictable four-step path regardless of whether the visit is in-person or remote.

Step 1: Schedule a qualifying visit. Any licensed DC prescriber can initiate osteoporosis therapy. Endocrinologists, rheumatologists, and internists see the highest volume of osteoporosis patients in DC, but family medicine physicians and geriatricians routinely prescribe alendronate as well. Telehealth platforms licensed in DC can complete this visit synchronously via video or, in some cases, asynchronously through a questionnaire review.

Step 2: Complete required diagnostic work. Before writing a prescription, a clinician needs a current DEXA scan (within the past 24 months is the standard accepted by most DC insurers), a basic metabolic panel to check serum calcium and creatinine/eGFR, and a 25-hydroxyvitamin D level [5]. Alendronate is contraindicated when eGFR falls below 35 mL/min/1.73 m² because renal clearance is the drug's sole elimination pathway [4]. A 25-OH vitamin D below 20 ng/mL should be corrected with supplementation before or alongside bisphosphonate initiation, per NIH Office of Dietary Supplements guidance [8].

Step 3: Receive and fill the prescription. Once a DC prescriber signs the prescription electronically, it routes to any DC-licensed retail or mail-order pharmacy. Generic alendronate 70 mg tablets cost under $15 per month at most DC-area pharmacies without insurance, and GoodRx-type discount programs may reduce that further [9]. Insured patients on DC Medicaid require prior authorization (see section below).

Step 4: Begin therapy with the correct administration protocol. Alendronate must be taken on an empty stomach with 6-8 oz of plain water, at least 30 minutes before the first food, drink, or other medication of the day, and the patient must remain upright for at least 30 minutes afterward to minimize esophageal irritation [4].

Telehealth Prescribing for Fosamax in the District of Columbia

DC law explicitly permits telehealth prescribing for non-controlled medications, including alendronate, after an appropriate clinical evaluation [6]. A prescriber does not need to have conducted a prior in-person visit; a synchronous video encounter is sufficient to establish a valid prescriber-patient relationship under DC telehealth regulations.

A 2023 review in the Journal of Bone and Mineral Research found that telehealth delivery of fracture liaison services produced equivalent rates of bisphosphonate initiation compared to in-person liaison programs, with medication adherence at 12 months reaching 68% in both arms [10]. That evidence base supports using remote visits as a clinically equivalent pathway for DC residents who face transportation barriers, work constraints, or mobility limitations.

When using a telehealth platform to obtain alendronate in DC, patients should confirm three things before booking: that the platform holds an active DC telehealth prescribing license, that a board-certified physician or qualified advanced practice provider reviews every prescription, and that the platform can send the prescription directly to a DC-licensed pharmacy or to the patient's preferred mail-order pharmacy.

Most DC telehealth platforms complete the prescriber review within 24 to 48 hours of a completed asynchronous intake or a synchronous video visit. Total time from initial appointment to prescription-in-hand at a local pharmacy is typically 3 to 7 business days when all required labs are already on file [10].

Labs Required Before Fosamax Is Prescribed in DC

A clinician ordering alendronate for the first time needs four key data points, each grounded in the drug's mechanism and safety profile.

DEXA scan. Bone mineral density measured at the lumbar spine and hip by dual-energy X-ray absorptiometry (DEXA) establishes the T-score needed to justify therapy. The BHOF 2022 guideline recommends pharmacologic treatment at T-score at or below -2.5, or at or below -1.0 if the 10-year FRAX probability of major osteoporotic fracture exceeds 20% or hip fracture exceeds 3% [5]. DC Medicare and Medicaid cover DEXA scans every 24 months for qualifying beneficiaries [11].

Serum calcium. Hypercalcemia is a contraindication to bisphosphonate therapy; hypocalcemia must be corrected before initiating treatment because alendronate can transiently lower calcium further during active bone uptake [4]. A standard comprehensive metabolic panel (CMP) captures both calcium and creatinine in a single blood draw.

eGFR / serum creatinine. Because alendronate is renally excreted unchanged, the FDA label specifies that the drug is not recommended when creatinine clearance falls below 35 mL/min [4]. Prescribers in DC should obtain a CMP rather than a standalone creatinine to catch concurrent electrolyte abnormalities.

25-hydroxyvitamin D. The NIH Office of Dietary Supplements notes that vitamin D deficiency is prevalent in up to 42% of U.S. adults [8]. Starting a bisphosphonate in a severely vitamin D-deficient patient risks hypocalcemia and reduces the drug's net effect on bone-mineral density. Most DC prescribers target 25-OH vitamin D above 30 ng/mL before or concurrently with alendronate initiation [5].

Optional pre-treatment labs that some DC endocrinologists order include serum PTH (to rule out primary hyperparathyroidism as a secondary cause), a complete blood count, and thyroid-stimulating hormone if the clinical picture suggests thyroid pathology contributing to bone loss [7].

DC Medicaid Prior Authorization for Fosamax

DC Medicaid covers alendronate under its preferred drug list, but coverage requires prior authorization (PA) in most managed care plan formularies. The PA request must document a confirmed diagnosis of osteoporosis or osteopenia with elevated fracture risk, a current DEXA result, and evidence that the patient has been counseled on non-pharmacologic measures such as calcium and vitamin D supplementation and weight-bearing exercise [12].

Most DC Medicaid managed care organizations process PA requests within 3 business days for standard review and within 72 hours for urgent requests. Generic alendronate 70 mg is almost always approved on first submission when DEXA documentation and the treating clinician's clinical notes accompany the request. If a formulary exception is needed for the branded Fosamax rather than generic alendronate, the prescriber must document a clinical reason the generic is inadequate, which DC Medicaid reviewers rarely accept for a bioequivalent product [12].

DC residents covered by private insurance through the ACA marketplace should check their plan's formulary tier for alendronate. Most silver and gold ACA plans in DC list generic alendronate on Tier 1 or Tier 2, with copays ranging from $0 to $15 per monthly fill [9].

503A Compounding Pharmacies in DC and Alendronate

A 503A pharmacy is a traditional compounding pharmacy regulated under state (DC) pharmacy law and the federal Food, Drug, and Cosmetic Act. Unlike 503B outsourcing facilities, which produce large batches, 503A pharmacies compound patient-specific preparations based on a valid individual prescription [13].

DC-licensed 503A pharmacies may compound alendronate oral solutions or alternative dose forms for patients who cannot tolerate standard tablets. This applies, for example, to patients with swallowing difficulties, those who need a dose form not commercially available, or those with confirmed sensitivity to an excipient in the branded or generic tablet. The FDA's current compounding guidance specifies that 503A pharmacies may not compound a drug that is essentially a copy of a commercially available product without a documented clinical difference from the standard formulation [13].

A 503A pharmacy in DC may also ship a compounded alendronate preparation to a DC-resident patient, provided the prescription was issued by a DC-licensed prescriber and the pharmacy holds an active DC dispensing license. Patients considering this route should verify the pharmacy's DC licensure status through the DC Board of Pharmacy, which maintains an online license verification database [14].

Transferring a Fosamax Prescription to DC

Patients relocating to Washington DC from another state who already take alendronate have two options for continuing therapy without interruption.

The simpler path is a direct prescription transfer. Under DC pharmacy law, a licensed DC pharmacist may transfer a non-controlled prescription from an out-of-state pharmacy to a DC pharmacy as a one-time transfer [14]. The DC pharmacist contacts the originating pharmacy, verifies the prescription, and records the transfer. The remaining refills (if any) are available at the DC pharmacy; the original pharmacy record is voided.

The more thorough approach, and the one most DC prescribers recommend for long-term continuity, is to establish care with a DC-based provider who can re-evaluate bone-mineral density, order updated labs, and write a new DC prescription. The American Society for Bone and Mineral Research recommends a DEXA scan every 1 to 2 years during active bisphosphonate therapy to assess treatment response [15]. If the patient's last DEXA is more than 24 months old, a new scan is medically appropriate at the time of care transfer.

Alendronate Dosing and Administration in DC Clinical Practice

The standard alendronate regimen for postmenopausal osteoporosis and male osteoporosis is 70 mg once weekly as an oral tablet [4]. For glucocorticoid-induced osteoporosis, the labeled dose is 5 mg daily (or 10 mg daily for postmenopausal women not receiving estrogen) [4]. Paget's disease requires 40 mg daily for 6 months, a separate indication rarely initiated by primary care in DC without specialist input.

Co-administration with calcium and vitamin D is standard. The BHOF guideline recommends 1,000 to 1 to 200 mg elemental calcium daily from diet and supplements combined, plus 800 to 1 to 000 IU of vitamin D3 daily for patients on bisphosphonate therapy [5]. DC endocrinologists at academic centers including GWU and MedStar Georgetown typically titrate vitamin D supplements to maintain serum 25-OH vitamin D above 30 ng/mL throughout treatment [7].

Duration of therapy is a clinical decision that has generated substantial debate. A post-hoc analysis of the FLEX trial (N=1,099) showed that women who continued alendronate for 10 years had a statistically significant reduction in clinical vertebral fractures compared to those who stopped at 5 years (relative risk 0.55 to 95% CI 0.38-0.80, P<0.001), but no significant difference in hip fracture rates [16]. The FDA's 2016 drug safety communication recommended that prescribers reassess the need for continued bisphosphonate therapy after 3 to 5 years, considering each patient's fracture risk profile [4].

Side Effects and Safety Monitoring During DC Prescribing

Alendronate's most common adverse effect is upper gastrointestinal irritation, including esophageal reflux, esophagitis, and gastric ulceration. The FIT trial reported GI adverse events in approximately 7% of the alendronate group versus 6% in the placebo group at 3 years, a difference that was not statistically significant but underscored the importance of proper administration technique [1].

Two rare but serious adverse effects require monitoring: osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF). The American Dental Association's 2011 expert panel placed the incidence of bisphosphonate-related ONJ at 0.01% to 0.1% for oral bisphosphonate users [17]. AFF risk rises with prolonged duration; a 2011 NEJM report documented an AFF incidence of 3.2 to 50 per 100,000 person-years, increasing sharply after 5 years of continuous use [18]. DC prescribers routinely ask about thigh or groin pain at each follow-up visit as a screening question for prodromal AFF.

Patients who require invasive dental procedures while on alendronate should notify their dentist of their medication use. DC-area oral surgeons and periodontists are familiar with the small ONJ risk and will coordinate care accordingly. No evidence currently supports stopping alendronate before routine dental cleanings or simple fillings [17].

Finding Alendronate at DC-Area Pharmacies

Generic alendronate 70 mg is stocked at every major retail pharmacy chain operating in Washington DC, including CVS, Walgreens, Safeway, Giant Food, and several independent pharmacies in neighborhoods such as Columbia Heights, Capitol Hill, and Dupont Circle. Mail-order pharmacies, including those affiliated with major DC insurers, dispense a 90-day supply and may offer lower per-tablet costs for patients with high-deductible plans [9].

Patients without insurance who need cost assistance may access the Pfizer Patient Assistance Program (Fosamax branded) or the NeedyMeds database, which lists current generic alendronate discount programs valid at DC pharmacies [9]. At cash-pay prices, a 4-tablet (4-week) blister pack of generic alendronate 70 mg costs approximately $10 to $18 at DC-area pharmacies as of mid-2025.